Seroconversion after SARS‐CoV‐2 vaccination is protective against severe COVID‐19 disease in heart transplant recipients

Seroconversion after SARS‐CoV‐2 vaccination is protective against severe COVID‐19 disease in heart transplant recipients

Abstract Background Heart transplant (HTX) recipients are prone to develop complications after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Vaccination is often ineffective due to weaker immunogenicity. In this high‐volume single‐center study, we aimed to determine factors...

Full description

Bibliographic Details
Main Authors: Szilvia Kugler, Dorottya Katalin Vári, Dániel Sándor Veres, Ákos Király, Tímea Teszák, Nóra Parázs, Zoltán Tarjányi, Zsófia Drobni, Zsófia Szakál‐Tóth, Gyula Prinz, Pál Miheller, Béla Merkely, Balázs Sax
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Immunity, Inflammation and Disease
Subjects:
antibody
COVID‐19
heart transplantation
immunosuppression
SARS‐CoV‐2
seroconversion
Online Access:https://doi.org/10.1002/iid3.1086

Internet

https://doi.org/10.1002/iid3.1086

Similar Items